DOI: 10.12890/2020_001702
Thrombocytopenia in the Course of COVID-19 Infection
Authors
-
Noel Lorenzo-Villalba
Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
-
Abrar-Ahmad Zulfiqar
Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
-
Marc Auburtin
Service de Médecine Interne, Centre Hospitalier d’Epinal, Epinal, France
-
Marie Helene Schuhmacher
Service de Médecine Interne, Centre Hospitalier d’Epinal, Epinal, France
-
Alain Meyer
Service de Rhumatologie, Hôpitaux Universitaires de Strasboug, Strasbourg, France
-
Yasmine Maouche
Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
-
Olivier Keller
Service de Médecine Interne, Centre Hospitalier de Haguenau, Haguenau, France
-
Emmanuel Andres
Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
noellorenzo@gmail.com
Keywords
COVID-19, thrombocytopenia, immune thrombocytopenia, immunoglobulins, eltrombopag
Abstract
We report three cases of severe thrombocytopenia during COVID-19 infection associated with either cutaneous purpura or mucosal bleeding. The initial investigations ruled out other causes of thrombocytopenia. Two of the patients were treated with intravenous immunoglobulins and eltrombopag, while the third recovered spontaneously. A good clinical and biological response was achieved in all patients leading to hospital discharge.
View the entire article
Downloads
How to Cite
1.
Lorenzo-Villalba N, Zulfiqar A-A, Auburtin M, Schuhmacher MH, Meyer A, Maouche Y, et al. Thrombocytopenia in the Course of COVID-19 Infection. EJCRIM [Internet]. 2020 May 7 [cited 2026 Nov. 3];7(6). Available from:
https://ejcrim.com/index.php/ejcrim/article/view/1702